Loading people...
Carl Byers is a Partner at F-Prime Capital and an Adjunct Lecturer at the Harvard Kennedy School, based in the Greater Boston Area. He previously served as the founding Chief Financial Officer of athenahealth from 1997 to 2010, where he oversaw the finance, legal, and technology teams while leading the company's 2007 initial public offering. Before his executive tenure at athenahealth, Byers worked as a Senior Consultant in financial services and health insurance at Booz Allen & Hamilton. In his current venture capital role, he has directed investments into prominent digital health companies, including backing Iora Health before its $2.1 billion acquisition by One Medical and PatientPing prior to its $500 million sale. Byers leverages his extensive operational and financial background to focus on early-stage venture capital investments across the healthcare IT and digital health services sectors.
Carl Byers serves as a distinguished Partner at F-Prime Capital Partners, a global venture capital firm renowned for its strategic investments in groundbreaking companies. Based in Cambridge, Massachusetts, Mr. Byers is a pivotal member of the firm's healthcare investment team, bringing extensive operational and investment expertise to the table. His primary focus lies within the dynamic and rapidly evolving healthcare sector, where he actively seeks out and champions innovative companies poised to transform patient care.
Mr. Byers' investment strategy at F-Prime Capital Partners is deeply rooted in identifying opportunities across several key healthcare verticals. He specializes in biotechnology, medical devices, digital health, and diagnostics, demonstrating a keen eye for disruptive technologies and solutions that address significant unmet medical needs. His portfolio reflects a commitment to supporting companies developing novel therapeutics, advanced medical technologies, and digital platforms designed to improve healthcare delivery and outcomes. He is known for his hands-on approach, often taking active board roles to guide portfolio companies through critical growth stages, from early stage development to market leadership.
Before joining F-Prime Capital Partners in 2012, Carl Byers built a robust career marked by both entrepreneurial success and strategic investment leadership. He notably co-founded and served as the Chief Operating Officer and Chief Financial Officer of Generation Health, a pioneering company focused on personalized medicine and pharmacogenomics, which was successfully acquired by CVS Caremark. This experience provided him with invaluable insights into building and scaling healthcare enterprises. Prior to Generation Health, Mr. Byers was a Principal at Polaris Venture Partners, where he honed his skills in healthcare venture capital, identifying and nurturing promising early stage companies. His foundational career experience also includes a tenure at McKinsey & Company, a global management consulting firm, where he advised clients across various industries.
Carl Byers' academic background further underpins his strategic acumen. He earned his Master of Business Administration from Harvard Business School and holds a Bachelor of Arts from Dartmouth College. This blend of academic rigor and practical experience equips him with a comprehensive understanding of both the scientific and business aspects of the healthcare industry.
Throughout his career, Mr. Byers has been instrumental in the growth and success of numerous companies. His notable investments and board affiliations include Akouos (acquired by Eli Lilly), a genetic medicine company; Orchard Therapeutics, a commercial stage gene therapy company; Spero Therapeutics, focused on novel antibiotics; Denali Therapeutics, a biopharmaceutical company addressing neurodegenerative diseases; Rhythm Pharmaceuticals, developing therapies for rare genetic disorders of obesity; and Valo Health, a technology company transforming drug discovery and development. His contributions have consistently helped these companies achieve significant milestones, bringing innovative treatments and technologies closer to patients worldwide. Carl Byers continues to be a driving force in healthcare innovation, leveraging his expertise to shape the future of medicine through strategic venture capital.
Carl Byers is a Partner at F-Prime Capital Partners, a global venture capital firm. He is a seasoned investor and entrepreneur specializing in the healthcare sector, with a focus on biotechnology, medical devices, and digital health.
Carl Byers primarily invests in innovative healthcare companies. His focus areas include biotechnology, medical devices, digital health, and diagnostics, particularly those developing novel therapeutics and technologies to address significant medical needs.
Carl Byers works as a Partner at F-Prime Capital Partners. The firm has offices in Cambridge, MA, and London, UK, and he is based in Cambridge.
